Lifecore Biomedical, Inc. announced on September 23, 2025, that its compensation committee approved an inducement grant to a newly hired employee. The grant includes a restricted stock unit (RSU) award for 15,000 shares of common stock and stock options for 30,000 shares of common stock.
The awards were granted on September 22, 2025, as a material inducement for the employee to join Lifecore, in accordance with Nasdaq Listing Rule 5635(c)(4) under Lifecore’s Equity Inducement Plan.
The RSU award will vest on the third anniversary of the grant date, subject to continued employment. The stock options have an exercise price equal to the fair market value on the grant date and will vest over time, aligning employee incentives with the company's long-term success.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.